PlainRecalls
FDA Drug Low Class III Ongoing

Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30

Reported: November 26, 2025 Initiated: October 10, 2025 #D-0156-2026

Product Description

Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30

Reason for Recall

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Details

Units Affected
4,884 30-count bottles
Distribution
Nationwide in the USA.
Location
Panchmahal

Frequently Asked Questions

What product was recalled?
Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30. Recalled by Alembic Pharmaceuticals Limited. Units affected: 4,884 30-count bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 26, 2025. Severity: Low. Recall number: D-0156-2026.